In this episode we discuss:
What you’ll get out of this episode:
- Raquel’s academic background & introduction to drug development.
- The inspiration drawn from personal experiences and influential figures in the biotech industry.
- Challenges of co-founding multiple companies.
- The innovation behind Vincerx Pharma.
- The potential of antibody drug conjugates in modern medicine.
- Insights into Vincerx’s upcoming ADC VIP 943.
- The vision and goals for Vincerx in the coming years.
- Key learnings Raquel has drawn from her vast experience in the biotech world.
Watch
Listen
Read
The Pioneering Minds Behind Vincerx Pharma
In the latest episode of the Bio Breakthroughs podcast, host Jared S Taylor sits down with Raquel Izumi, COO and President at Vincerx Pharma. With a PhD in microbiology and immunology from UCLA and a rich background in drug development, Raquel unveils her journey and the significant role that Vincerx Pharma plays in the pharmaceutical landscape.
The Motivation Behind Drug Development
Raquel’s initial push towards drug development stems from personal experiences that drove her passion. Grateful for the research that saved her mother’s life from breast cancer, she’s committed to making a lasting difference in the medical world.
Unique Features of Vincerx’s Antibody Drug Conjugate
Vincerx is breaking ground in the antibody drug conjugate field. Focusing on the Magic Bullet concept, Vincerx aims to improve treatment efficacy while minimizing side effects by targeting only the cancer cells and sparing healthy ones. This unique approach, combined with proprietary linkers and payloads, offers a promising future for safer drug development.
Vincerx’s Promising Clinical Future
Raquel emphasizes the importance of real-world testing in humans. With their first candidate, VIP 943, set to enter clinics in the second half of 2023, Vincerx is poised to showcase its innovative drug solutions. They believe their technology will prove to be the next generation ADC technology, opening doors for partnerships with biotech firms worldwide.
WORD FROM OUR SPONSORS:
Our sponsor for this episode are Sage Growth Partners.
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
Learn more about Vincerx Pharma follow these links:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – LinkedIn – Twitter – YouTube – Newsletter –
